TOPM (Translational Oncotype Prediction Model): Development and Internal Validation of an Interpretable Clinicopathological Model for Pre-Test Estimation of High Oncotype DX Recurrence Score in Early Hormone Receptor–Positive, HER2-negative Breast Cancer

Can O., Uras C.

INTERNATIONAL JOURNAL OF DRUG DELIVERY TECHNOLOGY, vol.15, no.75, pp.42-52, 2026 (Scopus)